Activist Starboard took a position in Becton Dickinson, calling for the company to sell its life sciences business. The ...

In a regulatory filing, Becton Dickinson (BDX) disclosed that its director Jeffrey Henderson bought 1.5K shares of common stock on February ...

Citi analyst Joanne Wuensch maintained a Buy rating on Becton Dickinson (BDX – Research Report) today. The company’s shares closed last Friday ...

Jeffrey William Henderson, a director at Becton Dickinson & Co (NYSE:BDX), recently acquired 1,500 shares of the company's common stock. The purchase, which took place on February 10, 2025, was made ...

Medical technology company Becton, Dickinson and Company (NYSE:BDX) will be announcing earnings results tomorrow before market open. Here’s what to look for.

Becton Dickinson (BDX) rose 2.4% in premarket trading as reports surface of potential separation of its $30 billion life ...

Beldex has made itself a pioneer in privacy-targeted blockchain solutions. Its ecosystem consists of capabilities just like ...

BCAL Diagnostics Limited ( ASX:BDX ) is possibly approaching a major achievement in its business, so we would like ...

BD (NYSE: BDX) announced that its board unanimously authorized management to pursue the separation of its Life Sciences ...

William Blair analyst A. Brackmann anticipates that the medical instruments supplier will post earnings of $3.34 per share for […] ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...